AnalystConsensusTarget has decreased revenue growth from 24.0% to 19.5%, increased profit margin from 11.8% to 13.9% and decreased future PE multiple from 53.7x to 42.4x.

Organ Transplant Demand And International Expansion Will Unlock Future Opportunities

Shared on07 May 25Fair value Increased 23%

Shared on30 Apr 25Fair value Increased 4.99%

Shared on23 Apr 25

Shared on17 Apr 25Fair value Increased 0.28%

Shared on09 Apr 25Fair value Decreased 22%

Shared on02 Apr 25Fair value Increased 40%

Shared on26 Mar 25

Shared on19 Mar 25

Shared on10 Mar 25Fair value Decreased 24%

Shared on07 May 25
Fair value Increased 23%

Shared on30 Apr 25
Fair value Increased 4.99%

Shared on17 Apr 25
Fair value Increased 0.28%

Shared on09 Apr 25
Fair value Decreased 22%

Shared on02 Apr 25
Fair value Increased 40%

Shared on10 Mar 25
Fair value Decreased 24%